SLC12A3 and cardiac hypertrophy: The inhibition of NCC using chlorothiazide abrogated FGF23-induced heart hypertrophy suggesting that FGF23 may act as a potential regulator of renal Na+ reabsorption with downstream consequences, although patients with FGF23-related gain or loss of function mutations primarily show more severe defects in phosphate metabolism.